2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)

Size: px
Start display at page:

Download "2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older)"

Transcription

1 2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Disease (CAD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory reporting. Review your PQRS Submission Summary report, available after entering your data, to ensure this is not an issue. Each measure answer is identified as Performance Met (PM), Performance Not Met (PNM) or Performance Exclusion (PE). More information on this rule is available within the Covisint PQRS Web Application. Patient sample criteria for the CAD Measure Group are: patients aged 18 years and older with a specific diagnosis of CAD, accompanied by a specific patient encounter: One of the following diagnosis codes indicating coronary artery disease: ICD-10-CM: I20.0, I20.1, I20.8, I20.9, I21.01, I21.02, I21.09, I21.11, I21.19, I21.21, I21.29, I21.3, I21.4, I22.0, I22.1, I22.2, I22.8, I22.9, I24.0, I24.1, I24.8, I24.9, I25.10, I25.110, I25.111, I25.118, I25.119, I25.2, I25.5, I25.6, I25.700, I25.701, I25.708, I25.709, I25.710, I25.711, I25.718, I25.719, I25.720, I25.721, I25.728, I25.729, I25.730, I25.731, I25.738, I25.739, I25.750, I25.751, I25.758, I25.759, I25.760, I25.761, I25.768, I25.769, I25.790, I25.791, I25.798, I25.799, I25.810, I25.811, I25.812, I25.82, I25.83, I25.89, I25.9, Z95.1, Z95.5, Z98.61 Accompanied by: One of the following patient encounter codes: 99201, 99202, 99203, 99204, 99205, 99212, 99213, 99214, 99215, 99304, 99305, 99306, 99307, 99308, 99309, 99310, 99324, 99325, 99326, 99327, 99328, 99334, 99335, 99336, 99337, 99341, 99342, 99343, 99344, 99345, 99347, 99348, 99349, Measure #7 need only be reported if the patient has one of the following diagnosis codes indicating coronary artery disease and also has Left Ventricular Systolic Dysfunction (LVEF< 40%): ICD-10-CM: I20.0, I20.1, I20.8, I20.9, I24.0, I24.1, I24.8, I24.9, I25.10, I25.110, I25.111, I25.118, I25.119, I25.5, I25.6, I25.700, I25.701, I25.708, I25.709, I25.710, I25.711, I25.718, I25.719, I25.720, I25.721, I25.728, I25.729, I25.730, I25.731, I25.738, I25.739, I25.750, I25.751, I25.758, I25.759, I25.760, I25.761, I25.768, I25.769, I25.790, I25.791, I25.798, I25.799, I25.810, I25.811, I25.812, I25.82, I25.83, I25.89, I25.9, Z95.1, Z95.5, Z98.61 Left ventricular ejection fraction (LVEF) < 40%: G8694 **Note: Refer to the Covisint PQRS2016 Applicable Measure Group Codes document which contains a list of diagnosis, encounter, and procedure codes for each measures group. Not all measures groups require all 3 code types.

2 Page 2 of 8 Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Practice Medical Record Number: Patient Insured - Traditional Medicare*: Medicare Advantage: Other: *Note: A minimum of 11 patients must be Traditional Medicare Part B Appointment Date: / / (1/1/16 12/31/16) mm dd yyyy ICD-10 Diagnosis Code: CPT Encounter (visit) Code: CPT Procedure Code: N/A REFER TO THE CORONARY ARTERY DISEASE (CAD) MEASURES GROUP WITHIN THE CMS 2016 PQRS MEASURES GROUPS SPECIFICATIONS MANUAL FOR CLINICAL RECOMMENDATIONS FURTHER INFORMATION.

3 Page 3 of 8 Physician Quality Reporting Measure # 6 : Coronary Artery Disease (CAD): Antiplatelet Therapy Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12- month period who were prescribed aspirin or clopidogrel Prescribed May include prescription given to the patient for aspirin or clopidogrel at one or more visits in the measurement period OR patient already taking aspirin or clopidogrel as documented in current medication list. Aspirin or clopidogrel prescribed - PM Aspirin or clopidogrel not prescribed for PE Document reason in medical chart Medical Patient System Aspirin or clopidogrel not Prescribed, reason not otherwise specified - PNM

4 Page 4 of 8 Physician Quality Reporting Measure # 7 : Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior MI or LVSD (LVEF <40%) Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period who also have a prior MI OR a current or prior LVEF < 40% who were prescribed beta-blocker therapy May include prescription given to the patient for betablocker therapy at one or more visits in the measurement period OR patient already taking beta-blocker therapy as documented in current medication list. For patients with prior LVEF < 40%, beta-blocker therapy includes the following: bisoprolol, carvedilol, or sustained release metoprolol succinate. For patients with prior MI, beta-blocker therapy includes any agent within the beta-blocker drug class. NOTE: In order for the patient to be considered for the measure, the diagnosis of CAD must be an active diagnosis and patient could have been diagnosed prior to the denominator eligible visits within the measurement year. The reporting numerator options contained within this specification are represented differently than the corresponding individual measure. Reference this specification only in order to satisfactorily report the measures group. Beta-blocker therapy prescribed or currently being taken - PM Documentation of reason(s) for not prescribing beta-blocker therapy - PE Beta-blocker therapy not prescribed, reason not given - PNM Patient does not have LVSD not eligible Medical Patient System For definitions and further information refer to the measures groups specifications manual

5 Page 5 of 8 Physician Quality Reporting Measure # 128 : Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-up Percentage of patients aged 18 years and older with a documented BMI during the current encounter or during the previous six months when the BMI is outside of normal parameters, a follow-up plan is documented during the encounter or during the previous six months of the encounter An eligible professional or their staff is required to measure both height and weight. Both the height and the weight must be measured within six months of the encounter and may be obtained from separate encounters. Self-reported values cannot be used. The documentation of a follow-up plan must be based on the most recent documented BMI within the previous six months. NOTE: BMI normal parameters are as follows: age BMI 18.5 and < 25 ; age 65 and older BMI 23 and < 30 Follow-Up Plan Proposed outline of treatment to be conducted as a result of a BMI out of normal parameters. A follow-up plan may include but is not limited to: documentation education, a referral (e.g., a registered dietician, nutritionist, occupational therapist, physical therapist, primary care provider, exercise physiologist, mental health professional, or surgeon), pharmacological interventions, dietary supplements, exercise counseling, or nutrition counseling. Not Eligible for BMI Calculation or Follow-Up Plan A patient is not eligible if one or more of the following reasons are documented: Patient is receiving palliative care Patient is pregnant Patient refuses BMI measurement (refuses height and/or weight) Any other reason documented in the medical record by the provider why BMI calculation or follow-up plan was not appropriate Patient is in an urgent or emergent medical situation where time is of the essence, and to delay treatment would jeopardize the patient s health status. BMI is documented within normal parameters and no follow-up plan is required - PM BMI is documented above normal parameters and a follow-up plan is documented - PM BMI is documented below normal parameters and a follow-up plan is documented - PM Documentation the patient is not eligible for BMI calculation for follow-up plan - PE BMI not documented and no reason is given - PNM BMI documented outside normal parameters, no follow-up plan documented, no reason given - PNM

6 Page 6 of 8 Physician Quality Reporting Measure # 130 : Documentation of Current Medications in the Medical Record Percentage of visits for patients aged 18 years and older for which the eligible professional attests to documenting a list of current medications using all immediate resources available on the date of the encounter. Eligible professional attests to documenting, updating or reviewing a patient s current medications using all immediate resources available on the date of encounter. This list must include ALL known prescriptions, over-the counters, herbals, and vitamin/mineral/dietary (nutritional) supplements must contain the medications name, dosages, frequency and route of administration Not Eligible - A patient is not eligible if the following reason is documented: Patient is in an urgent or emergent medical situation where time is of the essence and to delay treatment would jeopardize the patient s health status. Eligible professional attests to documenting in the medical record they obtained, updated, or reviewed the patient s current medications including no medications - PM Eligible professional attests to documenting in the medical record the patient is not eligible for a current list of medications being obtained, updated, or reviewed by the eligible professional - PE Current list of medications not documented as obtained, updated, or reviewed by the eligible professional, reason not given - PNM For definitions and further information refer to the measures groups specifications manual

7 Page 7 of 8 Physician Quality Reporting Measure # 226 : Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention Percentage of patients aged 18 years and older who were screened for tobacco use one or more times within 24 months who received cessation counseling intervention if identified as a tobacco user Note: In the event that a patient is screened for tobacco use and identified as a user but did not receive tobacco cessation counseling, choose answer option tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified. Tobacco Use includes any type of tobacco. Cessation Counseling Intervention includes brief counseling (3 minutes or less) and/or pharmacotherapy. Patient screened for tobacco use received tobacco cessation intervention (counseling, pharmacotherapy, or both), if identified as a tobacco user - PM Current tobacco non-user - PM Documentation of medical reason(s) for not screening for tobacco use (e.g., limited life expectancy, other medical reasons) - PE Tobacco screening OR tobacco cessation intervention not performed, reason not otherwise specified - PNM

8 Page 8 of 8 Physician Quality Reporting Measure # 242 : Coronary Artery Disease (CAD): Symptom Management Percentage of patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12-month period with an evaluation of level of activity and an assessment of whether anginal symptoms are present or absent with appropriate management of anginal symptoms within a 12-month period Evaluation of level of activity and evaluation of presence or absence of angina symptoms should include: Documentation of Canadian Cardiovascular Society (CCS) Angina Class OR Completion of a disease-specific questionnaire (e.g., Seattle Angina Questionnaire or other validated questionnaire) to quantify angina and level of activity For definitions and further information refer to the measures groups specifications manual Severity of angina assessed by level of activity Angina present Plan of care to manage anginal symptoms documented - PM Severity of angina assessed by level of activity Angina absent - PM Severity of angina assessed by level of activity Angina present Documentation of reason(s) for not providing any specified element of plan of care to achieve control of anginal symptoms - PE Medical Patient System Severity of angina assessed by level of activity Angina present Plan of care to achieve control of angina symptoms was not performed, reason not otherwise specified - PNM Severity of angina not assessed, reason not otherwise specified - PNM

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Sleep Apnea (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Chronic Obstructive Pulmonary Disease (COPD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse

More information

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement

2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement 2016 Physician Quality Reporting System Data Collection Form: Total Knee Replacement IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory reporting.

More information

Patient sample criteria for the Preventive Care Measure Group are patients aged 50 years and older with a specific patient encounter:

Patient sample criteria for the Preventive Care Measure Group are patients aged 50 years and older with a specific patient encounter: 2016 Physician Quality Reporting System Data Collection Form: Preventive Care (for patients aged 50 and older) NOTE: Individual measures may have more restrictive age and gender requirements. IMPORTANT:

More information

2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older)

2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older) 2016 Physician Quality Reporting System Data Collection Form: Multiple Chronic Conditions (for patients aged 66 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)

More information

2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2015 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered satisfactory

More information

2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Sinusitis (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

2015 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older)

2015 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older) 2015 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures)

More information

2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older)

2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) 2014 Physician Quality Reporting System Data Collection Form: Oncology (for patients aged 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Medical Record

More information

2016 Physician Quality Reporting System Data Collection Form: Parkinson s Disease (for patients aged 18 and older)

2016 Physician Quality Reporting System Data Collection Form: Parkinson s Disease (for patients aged 18 and older) 2016 Physician Quality Reporting System Data Collection Form: Parkinson s Disease (for patients aged 18 and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse measures) is not considered

More information

2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY

2014 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY Measure #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) 2014 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6. Coronary Artery Disease (CAD): Antiplatelet

More information

2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64)

2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) 2014 Physician Quality Reporting System Data Collection Form: Asthma (for patients aged 5-64) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Patient Insured - Traditional

More information

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW

CORONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW CONARY ARTERY DISEASE (CAD) MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: 2016 PQRS MEASURES IN CONARY ARTERY DISEASE (CAD) MEASURES GROUP: #6 Coronary Artery Disease (CAD): Antiplatelet

More information

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older)

2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) 2016 Physician Quality Reporting System Data Collection Form: Coronary Artery Bypass Graft (CABG) (for patients aged 18 years and older) IMPORTANT: Any measure with a 0% performance rate (100% for inverse

More information

2014 Oncology Measures Group Overview

2014 Oncology Measures Group Overview 2014 Oncology Measures Group Overview The Oncology Measures Group is a reporting option that significantly reduces the burden of participation in the Physician Quality Reporting System (PQRS). Source:

More information

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name

Program Metrics. New Unique ID. Old Unique ID. Metric Set Metric Name Description. Old Metric Name Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for, Atrial Fibrillation, Hypertension and.

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Quality Payment Program: Cardiology Specialty Set Title Number CMS Reporting Method(s) Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for

More information

Quality Payment Program: Cardiology Specialty Measure Set

Quality Payment Program: Cardiology Specialty Measure Set Measure Title * Reportable via PINNACLE α Reportable via Diabetes Collaborative CQMC v1.0 Measure High Priority Measure Cross Cutting Measure Heart Failure (HF): Angiotensin- Converting Enzyme (ACE) Inhibitor

More information

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0.

New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. New PINNACLE Measures The below measures for PINNACLE will be added as new measures to the outcomes reporting starting with Version 2.0. Measure Steward Measure Name Measure Description Rationale for Adding

More information

Practice-Level Executive Summary Report

Practice-Level Executive Summary Report PINNACLE Registry Metrics 0003, Test Practice_NextGen [Rolling: 1st April 2015 to 31st March 2016 ] Generated on 5/11/2016 11:37:35 AM American College of Cardiology Foundation National Cardiovascular

More information

2014 ACO GPRO Audit What this means for your practice. Sheree M. Arnold ACO Clinical Transformation Specialist

2014 ACO GPRO Audit What this means for your practice. Sheree M. Arnold ACO Clinical Transformation Specialist 2014 ACO GPRO Audit What this means for your practice Sheree M. Arnold ACO Clinical Transformation Specialist Agenda Catholic Medical Partners ACO overview Attribution and sampling of patients ACO quality

More information

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set

Performance and Quality Measures 1. NQF Measure Number. Coronary Artery Disease Measure Set Unless indicated, the PINNACLE Registry measures are endorsed by the American College of Cardiology Foundation and the American Heart Association and may be used for purposes of health care insurance payer

More information

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process

2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process Quality ID #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction

2) Patients who are 18 years and older with a diagnosis of CAD or history of cardiac surgery who have a prior myocardial infarction Measure #7 (NQF 0070): Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF < 40%) National Quality Strategy Domain: Effective

More information

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET

PQRS in TRAKnet 2015 GUIDE TO SUBMIT TING AND REPORTING PQRS IN 2015 THROUGH TRAKNET PQRS in TRAKnet 2015 GUIDE TO SUBMITTING AND REPORTING PQRS IN 2015 THROUGH TRAKNET What is PQRS? PQRS is a quality reporting program that uses negative payment adjustments to promote reporting of quality

More information

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11.

NOA 3rd Party Newsletter PQRS EDITION - Page 1 CONTENTS. Traffic Sheet P.3. Flowsheet & Detailed Directions P.11. NOA 3rd Party Newsletter - 2016 PQRS EDITION - Page 1 CONTENTS EYE MEASURES Measure #12 :Primary Open-Angle Glaucoma: Optic Nerve Evaluation Traffic Sheet P.2. Flowsheet & Detailed Directions P.8. Measure

More information

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT I S S U E Winter M A R C H 2 0 1 4 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, LICSW, CT Senior

More information

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents

Comprehensive ESRD Care (CEC) Model Proposed Quality Measures for Public Comment. Table of Contents Comprehensive ESRD Care (CEC) Model Proposed Quality s for Public Comment Table of Contents Page # Introduction 3 Summaries by Domain Technical Expert Panel Recommended CEC Quality s 4 s that were recommended

More information

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT

PracticePerspectives. Winter. Using Medicare PQRS 2014 Individual Measures in Clinical Practice* Mirean Coleman, LICSW, CT I S S U E Winter M A R C H 2 0 1 4 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, LICSW, CT Senior

More information

Controlled IOP Uncontrolled IOP Diabetes with or without retinopathy

Controlled IOP Uncontrolled IOP Diabetes with or without retinopathy PQRS Guidelines I. Introduction A. The reporting of these additional codes are used to determine the quality of care a provider gives to patients with certain diseases. B. All PQRS codes including the

More information

2014 Physician Quality Reporting System Data Collection Form: Cataracts (for patients aged 18 and older)

2014 Physician Quality Reporting System Data Collection Form: Cataracts (for patients aged 18 and older) 2014 Physician Quality Reporting System Data Collection Form: Cataracts (for patients aged 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender: M F Patient Insured

More information

2014 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older)

2014 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older) 2014 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients aged 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy

More information

Tobacco Use: Screening & Cessation Intervention

Tobacco Use: Screening & Cessation Intervention Tobacco Use: Screening and Cessation Intervention MSSP ACO Measure Tobacco Use: Screening & Cessation Intervention Domain: Preventive Care and Screening ACO 17 PREV- 10 PQRS - 226 NQF 0028 Measure Steward:

More information

2017 MSSP Clinical Quality Measures

2017 MSSP Clinical Quality Measures *The information contained in this document relies heavily on information supplied by CMS. GPRO CARE-1 (NQF 0097): Medication Reconciliation Post-Discharge DESCRIPTION: Percentage of discharges from any

More information

Compass PTN Core Measures

Compass PTN Core Measures Compass PTN Core Measures emeasure ID: CMS122v5 NQF: 0059 QualityID: 001 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%) Patients 18-75 years of age with diabetes with a visit during the measurement

More information

PracticePerspectives. Winter. Reporting PQRS Measures for Medicare in Mirean Coleman, The National Association of Social Workers

PracticePerspectives. Winter. Reporting PQRS Measures for Medicare in Mirean Coleman, The National Association of Social Workers I S S U E Winter M A R C H 2 0 1 3 PracticePerspectives The National Association of Social Workers 750 First Street NE Suite 700 Washington, DC 20002-4241 SocialWorkers.org Mirean Coleman, MSW, LICSW,

More information

MACRA Quality Payment Program Guide. Sample page. Simplifying Medicare MIPS & APM reporting for practitioners. Power up your coding optum360coding.

MACRA Quality Payment Program Guide. Sample page. Simplifying Medicare MIPS & APM reporting for practitioners. Power up your coding optum360coding. 2019 MACRA Quality Payment Program Guide Simplifying Medicare MIPS & APM reporting for practitioners Power up your coding optum360coding.com Contents Chapter 1. MACRA and the Quality Payment Program...

More information

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age years BMI 18.5 and < 25 kg/m 2

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age years BMI 18.5 and < 25 kg/m 2 Measure #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2015 PQRS OPTIONS F INDIVIDUAL MEASURES:

More information

MIPS: Quality Direct EHR Manual for Aprima Users

MIPS: Quality Direct EHR Manual for Aprima Users MIPS: Quality Direct EHR Manual for Aprima Users CONTENTS QUALITY INTRODUCTION... 5 CMS 2: SCREENING FOR CLINICAL DEPRESSION AND FOLLOWUP PLAN....6 CMS 22: SCREENING FOR HIGH BLOOD PRESSURE AND FOLLOWUP

More information

2017 Data Collection Form: Orthopedics Advanced

2017 Data Collection Form: Orthopedics Advanced 2017 Data Collection Form: Orthopedics Advanced Physician Name: The following Quality measures are included in this ADVANCED specialty set: o 21 Perioperative - Selection of Prophylactic Antibiotic o 23

More information

Clinical Quality Measures - Colorado SIM, TCPI

Clinical Quality Measures - Colorado SIM, TCPI Clinical Quality s - Colorado SIM, TCPI Aniety AOD Aniety Initiation and Engagement of Alcohol and Other Drug Dependence Treatment Not yet endorsed by 0004 e- - - 137v4 305 General Aniety Disorder GAD-7

More information

Discuss the Process for PQRS Reporting. Explain How Often Therapists Should Report

Discuss the Process for PQRS Reporting. Explain How Often Therapists Should Report 2016 Define PQRS Explain Who Should Participate Discuss the Process for PQRS Reporting Explain How Often Therapists Should Report Physician Quality Reporting System A quality reporting system for Medicare

More information

Age 18 years and older BMI 18.5 and < 25 kg/m 2

Age 18 years and older BMI 18.5 and < 25 kg/m 2 Quality ID #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

ASTHMA MEASURES GROUP OVERVIEW

ASTHMA MEASURES GROUP OVERVIEW ASTHMA MEASURES GROUP OVERVIEW 2015 PQRS OPTIONS F MEASURES GROUPS: 2015 PQRS MEASURES IN ASTHMA MEASURES GROUP: #53 Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting #110 Preventive

More information

Age 18 years and older BMI 18.5 and < 25 kg/m 2

Age 18 years and older BMI 18.5 and < 25 kg/m 2 Quality ID #128 (NQF 0421): Preventive Care and Screening: Body Mass Index (BMI) Screening and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2018 OPTIONS F INDIVIDUAL MEASURES:

More information

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40%

THERE ARE TWO SUBMISSION CRITERIA FOR THIS MEASURE: 1) Patients who are 18 years and older with a diagnosis of CAD with LVEF < 40% Quality ID #118 (NQF 0066): Coronary Artery Disease (CAD): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy - Diabetes or Left Ventricular Systolic Dysfunction

More information

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1

2015 PQRS Registry. Source Measure Title Measure Description CITIUS1 1 CQ-IQ covers 65 CMS defined measures that Eligible Providers (EPs) have to report on to assess quality of care provided to the patients. Version Supported: PQRS Registry 2015 65 measures Reporting Period:

More information

Measures Groups Specifications Manual

Measures Groups Specifications Manual 2015 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual Utilized by Individual Eligible Professionals Registry ONLY Reporting 12/22/2014 This manual contains specific guidance

More information

Clinical Quality Measures

Clinical Quality Measures Title Medicare Shared Savings Program Blue Cross Blue Shield Other CI Measures Clinical Quality Measures 2016 Reference Toolkit Version Date: 6/13/2016 Title Page 2016 Measures: Quality Codes Page 1 of

More information

ASTHMA MEASURES GROUP OVERVIEW

ASTHMA MEASURES GROUP OVERVIEW 2016 PQRS OPTIONS F MEASURES GROUPS: ASTHMA MEASURES GROUP OVERVIEW 2016 PQRS MEASURES IN ASTHMA MEASURES GROUP: #53 Asthma: Pharmacologic Therapy for Persistent Asthma Ambulatory Care Setting #110 Preventive

More information

IQSS 2019 QCDR and MIPS Measure Specifications

IQSS 2019 QCDR and MIPS Measure Specifications IQSS1 Hypogonadism: Serum T, CBC, PSA, IPSS within 6 months of Rx Percentage of patients with a Effective Clinical Patients with documented new diagnosis of hypogonadism receiving androgen replacement

More information

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner

Measure Owner Designation. AMA-PCPI is the measure owner. NCQA is the measure owner. QIP/CMS is the measure owner. AMA-NCQA is the measure owner 2011 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

DataDerm Quality Measures

DataDerm Quality Measures 01 MIPS 224 NQF 0562 DataDerm Quality s Melanoma: Overutilization of Imaging Studies 02 a & b MIPS 138 Melanoma: Coordination of Care 03 MIPS 137 NQF 0650 Melanoma: Continuity of Care Recall System Percentage

More information

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI)

Measurement Name Beta-Blocker Therapy Prior Myocardial Infarction (MI) Program Metrics The list below includes the metrics that will be calculated by the PINNACLE Registry for the outpatient office setting. These include metrics for Artery, Atrial Fibrillation, Hypertension

More information

2016 Internal Medicine Preferred Specialty Measure Set

2016 Internal Medicine Preferred Specialty Measure Set 1 0059 Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period 5 0081 Registry, EHR, 9 0105

More information

2013 Hypertension Measure Group Patient Visit Form

2013 Hypertension Measure Group Patient Visit Form Please complete the form below for 20 or more unique patients meeting patient sample criteria for the measure group for the current reporting year. A majority (11 or more) patients must be Medicare Part

More information

2013 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients 18 and older)

2013 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients 18 and older) 2013 Physician Quality Reporting System Data Collection Form: Inflammatory Bowel Disease (IBD) (for patients 18 and older) Physician Name: Patient Name: Last First MI Date of Birth: / / mm dd yyyy Gender:

More information

2016 Cross-Cutting Measure Set

2016 Cross-Cutting Measure Set 1 0059 Diabetes: Hemoglobin A1c Poor Control: Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the 46 0097 Claims, Registry Medication Reconciliation Post Discharge:

More information

*NOTE: When reporting C P T code and 99239, it is recommended the measure be reported each time the code is submitted for hospital discharge.

*NOTE: When reporting C P T code and 99239, it is recommended the measure be reported each time the code is submitted for hospital discharge. Measure #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) 2014 PQRS OPTIONS

More information

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care

Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS F INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process

More information

2018 MIPS Reporting Family Medicine

2018 MIPS Reporting Family Medicine 2018 MIPS Reporting Family Medicine Quality Reporting Requirements: Report on 6 quality measures or a specialty measure set Include at least ONE outcome or high-priority measure Report on patients of All-Payers

More information

Consensus Core Set: Cardiovascular Measures Version 1.0

Consensus Core Set: Cardiovascular Measures Version 1.0 Consensus Core Set: Cardiovascular s NQF 0330 Hospital 30-day, all-cause, riskstandardized readmission rate (RSRR) following heart failure hospitalization 0229 Hospital 30-day, all-cause, riskstandardized

More information

American Gastroenterological Association (AGA) Colorectal Cancer (CRC) Screening and Surveillance Measures January 1, 2015 to December 31, 2015

American Gastroenterological Association (AGA) Colorectal Cancer (CRC) Screening and Surveillance Measures January 1, 2015 to December 31, 2015 2015 PQRS MEASURES F COLECTAL CANCER SCREENING QCDR: DHRP #1: DHRP #2: Colonoscopy Interval for Patients with a History of Adenomatous Polyps Avoidance of Inappropriate Use National Quality Strategy Domain:

More information

2016 Physician Quality Reporting System (PQRS) GPRO Web Interface Measures List 12/18/2015

2016 Physician Quality Reporting System (PQRS) GPRO Web Interface Measures List 12/18/2015 2016 Physician Quality Reporting System (PQRS) Web Interface 12/18/2015 NQF, ) Care Coordination/Patient Safety (CARE) s (2 s Individually Sampled) CARE-2 Falls: Screening for Future Fall Risk Only #318

More information

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW

ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP OVERVIEW 2014 PQRS OPTIONS F MEASURES GROUPS: 2014 PQRS MEASURES IN ISCHEMIC VASCULAR DISEASE (IVD) MEASURES GROUP: #204. Ischemic Vascular Disease (IVD):

More information

American College of Physicians Genesis Registry

American College of Physicians Genesis Registry Powered by Premier American College of Physicians Genesis Registry This registry has been approved by CMS as a Qualified Clinical Data Registry (QCDR) for Eligible Clinicians and group practices for the

More information

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health

Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health Measure #402: Tobacco Use and Help with Quitting Among Adolescents National Quality Strategy Domain: Community / Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY DESCRIPTION:

More information

Heart Failure Clinician Guide JANUARY 2016

Heart Failure Clinician Guide JANUARY 2016 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2016 Introduction This evidence-based guideline summary is based on the 2016 National Heart Failure Guideline.

More information

Measure Owner Designation. AMA-PCPI/NCQA (contract) is the measure owner. AMA-PCPI is the measure owner. AMA-PCPI/ASCO/NCCN is the measure owner

Measure Owner Designation. AMA-PCPI/NCQA (contract) is the measure owner. AMA-PCPI is the measure owner. AMA-PCPI/ASCO/NCCN is the measure owner 2012 EHR Measure Specifications The specifications listed in this document have been updated to reflect clinical practice guidelines and applicable health informatics standards that are the most current

More information

Heart Failure Clinician Guide JANUARY 2018

Heart Failure Clinician Guide JANUARY 2018 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Heart Failure Clinician Guide JANUARY 2018 Introduction This evidence-based guideline summary is based on the 2018 National Heart Failure Guideline.

More information

Meaningful Use Overview

Meaningful Use Overview Eligibility Providers may be eligible for incentives from either Medicare or Medicaid, but not both. In addition, providers may not be hospital based. Medicare: A Medicare Eligible Professional (EP) is

More information

Meaningful Use Simple Guide

Meaningful Use Simple Guide Meaningful Use Simple Guide 2011-2012 CORE Measures 1. CPOE for Medication Orders 2. Drug Interaction Checks * 3. Maintain Problem & Diagnosis List 4. eprescribing (erx) escripts 5. Active Medication List

More information

MEASURE SPECIFICATIONS

MEASURE SPECIFICATIONS QOPI REPTING REGISTRY (QCDR) 2018 QOPI 5 QOPI 11 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Combination chemotherapy

More information

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY

2016 PQRS OPTIONS FOR INDIVIDUAL MEASURES: CLAIMS, REGISTRY Measure #134 (NQF 0418): Preventive Care and Screening: Screening for Clinical Depression and Follow-Up Plan National Quality Strategy Domain: Community/Population Health 2016 PQRS OPTIONS FOR INDIVIDUAL

More information

Meaningful Use for Eligible Providers

Meaningful Use for Eligible Providers Meaningful Use for Eligible Providers Summary of Core and Menu objectives and Clinical Quality s Healthcare Technical Assistance Program, March 11, 2011 V.1.0Copyright 2011, Purdue Research Foundation

More information

HF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart

HF QUALITY MEASURES. Hydralazine/nitrate at discharge: Percent of black heart Get With The Guidelines - Heart Failure is the American Heart Association s collaborative quality improvement program, demonstrated to improve adherence to evidence-based care of patients hospitalized

More information

2010 Physician Quality Reporting Initiative Measures Groups Specifications Manual

2010 Physician Quality Reporting Initiative Measures Groups Specifications Manual 2010 Physician Quality Reporting Initiative Measures Groups Specifications Manual This manual contains specific guidance for reporting 2010 Physician Quality Reporting Initiative (PQRI) Measures Groups.

More information

HEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement

HEART FAILURE QUALITY IMPROVEMENT. American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement HEART FAILURE QUALITY IMPROVEMENT American Heart Association Shawni Smith Regional Director, Quality & Systems Improvement 1 DISCLOSURES NONE 2 3 WHY IS THIS IMPORTANT? WHY? Heart Failure Currently, an

More information

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group

Repeat ischaemic heart disease audit of primary care patients ( ): Comparisons by age, sex and ethnic group Repeat ischaemic heart disease audit of primary care patients (2002-2003): Comparisons by age, sex and ethnic group Baseline-repeat ischaemic heart disease audit of primary care patients: a comparison

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

Quality Measures MIPS CV Specific

Quality Measures MIPS CV Specific Quality Measures MIPS CV Specific MEASURE NAME Atrial Fibrillation and Atrial Flutter: Chronic Anticoagulation Therapy CAHPS for MIPS Clinician/Group Survey Cardiac Rehabilitation Patient Referral from

More information

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017

Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Kaiser Permanente National CLINICAL PRACTICE GUIDELINES Coronary Artery Disease (CAD) Clinician Guide SEPTEMBER 2017 Introduction This Clinician Guide is based on the 2017 KP National Coronary Artery Disease

More information

Documentation Tips for Quality Measures

Documentation Tips for Quality Measures Documentation Tips for Quality Measures Electronic health records (EHRs) collect and organize notes, medication lists, and patient information using various formats. With providers also documenting this

More information

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes

Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Beta-blockers in Patients with Mid-range Left Ventricular Ejection Fraction after AMI Improved Clinical Outcomes Seung-Jae Joo and other KAMIR-NIH investigators Department of Cardiology, Jeju National

More information

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period

DENOMINATOR: All patients aged 18 years and older with a diagnosis of coronary artery disease seen within a 12 month period Quality ID #6 (NQF 0067): Coronary Artery Disease (CAD): Antiplatelet Therapy National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Management of Chronic Conditions 2019 COLLECTION

More information

2016 General Practice/Family Practice Preferred Specialty Measure Set

2016 General Practice/Family Practice Preferred Specialty Measure Set 1 0059 5 0081 41 N/A 50 N/A 65 0069, EHR 66 0002, EHR Effective Clinical Care Effective Clinical Care Effective Clinical Care Diabetes: Hemoglobin A1c (HbA1c) Poor Control (>9%): Percentage of patients

More information

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years

Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years Medicare Shared Savings Program Quality Measure Benchmarks for the 2014 and 2015 Reporting Years Introduction This document describes methods for calculating the quality performance benchmarks for Accountable

More information

Certified Health IT Transparency and Disclosure Information 2014 Edition

Certified Health IT Transparency and Disclosure Information 2014 Edition Certified Health IT Transparency and Disclosure Information 2014 Edition 2015 Edition Certified Health IT Transparency and Disclosure Information I. Disclaimer This Complete EHR is 2014 Edition compliant

More information

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge.

*NOTE: When submitting CPT code and 99239, it is recommended the measure be submitted each time the code is submitted for hospital discharge. Quality ID #5 (NQF 0081): Heart Failure (HF): Angiotensin-Converting Enzyme (ACE) Inhibitor or Angiotensin Receptor Blocker (ARB) Therapy for Left Ventricular Systolic Dysfunction (LVSD) National Quality

More information

2013 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual

2013 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual 2013 Physician Quality Reporting System (PQRS) Measures Groups Specifications Manual 12/19/2012 CPT only copyright 2012 American Medical Association. All rights reserved. CPT is a registered trademark

More information

MEASURE SPECIFICATIONS

MEASURE SPECIFICATIONS QOPI REPTING REGISTRY (QCDR) 2018 QOPI5 Title Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Description Percentage

More information

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS

QUALIFIED CLINICAL DATA REGISTRY (QCDR) 2017 MEASURE SPECIFICATIONS QOPI5 Chemotherapy administered to patients with metastatic solid tumor with performance status of 3, 4, or undocumented (Lower Score - Better) Percentage of adult patients with metastatic solid tumors

More information

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Performance Measurement Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians Writing Committee Amir Qaseem, MD,

More information

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0

Consensus Core Set: ACO and PCMH / Primary Care Measures Version 1.0 Consensus Core Set: ACO and PCMH / Primary Care s 0018 Controlling High Blood Pressure patients 18 to 85 years of age who had a diagnosis of hypertension (HTN) and whose blood pressure (BP) was adequately

More information

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome

2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Outcome Measure #445 (NQF 0119): Risk-Adjusted Operative Mortality for Coronary Artery Bypass Graft (CABG) National Quality Strategy Domain: Effective Clinical Care 2017 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY

More information

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group

Primary and Secondary Prevention of Cardiovascular Disease. Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group Primary and Secondary Prevention of Cardiovascular Disease Frank J. Green, M.D., F.A.C.C. St. Vincent Medical Group AHA Diet and Lifestyle Recommendations Balance calorie intake and physical activity to

More information

May 2016 CTC/OHIC Measure Specifications

May 2016 CTC/OHIC Measure Specifications Active Patients: Overarching Principles and Definitions Out patients seen by a primary care clinician of the PCMH anytime within the last 24 months. Definition of primary care clinician includes the following:

More information

Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436

Possible Denominator Codes Applicable to OMS * Le Fort Fractures 21346, 21347, 21348, 21422, 21423, 21432, 21433, 21435, 21436 2015 Individual PQRS s Eligible OMS #22: Perioperative Care: Discontinuation of Prophylactic Antibiotics (Non- Cardiac Procedures) Percentage of noncardiac surgical patients aged 18 years and older undergoing

More information